Meta-analysis and review: effectiveness, safety, and central port design of the intraocular collamer lens
Author:
Top Cited Papers
Open Access
- 1 June 2016
- journal article
- review article
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 10, 1059-1077
Abstract
The purpose of this review is to summarize relevant data from publications appearing in the peer-reviewed scientific literature over the past decade since US Food and Drug Administration approval of the implantable collamer lens (ICL), and, in particular, to review studies relating to sizing methodology, safety, and effectiveness, as well as more recent studies reporting clinical outcomes of the V4c Visian ICL with KS Aquaport, VICMO. A literature search was conducted using two databases, PubMed.gov and Science.gov, to identify all articles published after 2005 related to the Visian ICL (STAAR Surgical, Inc.). Articles were examined for their relevance to sizing methodology, clinical safety, and effectiveness, and the references cited in each article were also searched for additional relevant publications. The literature review revealed that all currently reported methods of determining the best-fit size of the ICL achieve similarly satisfactory results in terms of vault, the safe distance between the crystalline lens and the ICL. Specifically, meta-analysis demonstrated that sulcus-to-sulcus and white-to-white measurement-based sizing methods do not result in clinically meaningful nor statistically significant differences in vault (two-sample two-sided t-test using pooled mean and standard deviations; t (2,594)=1.33; P=0.18). The reported rates of complications related to vault are very low, except in two case series where additional risk factors such as higher levels of myopia and older age impacted the incidence of cataract. On the basis of preclinical studies and initial clinical reports, with up to 5 years of follow-up, the new VICMO central port design holds promise for further reduction of complications. Given its safety record and the significant improvement in vision and quality of life that the ICL makes possible, the benefits of ICL implantation outweigh the risks.Keywords
This publication has 76 references indexed in Scilit:
- Comparison of Optical Quality and Intraocular Scattering after Posterior Chamber Phakic Intraocular Lens with and without a Central Hole (Hole ICL and Conventional ICL) Implantation Using the Double-Pass InstrumentPLOS ONE, 2013
- Quality of Life in High Myopia before and after Implantable Collamer Lens ImplantationOphthalmology, 2010
- Toric implantable collamer lens for patients with moderate to severe myopic astigmatism: 12‐month follow‐upClinical & Experimental Ophthalmology, 2010
- Posterior Chamber Phakic Implantable Collamer Lens: Changes in Vault During 1 YearJournal of Refractive Surgery, 2010
- Ciliary Sulcus Diameter and Two Anterior Chamber Parameters Measured by Optical Coherence Tomography and VHF UltrasoundJournal of Refractive Surgery, 2009
- Direct Measurement of the Ciliary Sulcus Diameter by 35-Megahertz Ultrasound BiomicroscopyOphthalmology, 2007
- The Association between Myopia and Various Subtypes of Lens OpacityOphthalmology, 2005
- United States Food and Drug Administration clinical trial of the Implantable Collamer Lens (ICL) for moderate to high myopiaOphthalmology, 2004
- U.S. Food and Drug Administration clinical trial of the Implantable Contact Lens for moderate to high myopiaOphthalmology, 2003
- Quality of life in myopiaBritish Journal of Ophthalmology, 2000